{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:33:22Z","timestamp":1773282802196,"version":"3.50.1"},"reference-count":56,"publisher":"Elsevier","isbn-type":[{"value":"9780323989497","type":"print"}],"license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["320030_175585"],"award-info":[{"award-number":["320030_175585"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1016\/bs.apar.2022.05.002","type":"book-chapter","created":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T07:54:13Z","timestamp":1656489253000},"page":"47-73","source":"Crossref","is-referenced-by-count":6,"title":["Improving translational power in antischistosomal drug discovery"],"prefix":"10.1016","member":"78","reference":[{"issue":"9","key":"10.1016\/bs.apar.2022.05.002_bb0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005942","article-title":"Evaluation of the pharmacokinetic-pharmacodynamic relationship of praziquantel in the Schistosoma mansoni mouse model","volume":"11","author":"Abla","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"1","key":"10.1016\/bs.apar.2022.05.002_bb0015","doi-asserted-by":"crossref","first-page":"4776","DOI":"10.1038\/s41467-021-24958-0","article-title":"Whole-genome sequencing of Schistosoma mansoni reveals extensive diversity with limited selection despite mass drug administration","volume":"12","author":"Berger","year":"2021","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/bs.apar.2022.05.002_bb0020","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/0014-4894(80)90023-5","article-title":"Schistosoma mansoni: influence of the mouse host's sex, age, and strain on resistance to reinfection","volume":"50","author":"Bickle","year":"1980","journal-title":"Exp. Parasitol."},{"key":"10.1016\/bs.apar.2022.05.002_bb0025","first-page":"1","article-title":"Discovery of novel antischistosomal scaffolds from the open access pandemic response box","author":"Biendl","year":"2021","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/bs.apar.2022.05.002_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.exppara.2019.107793","article-title":"The phosphodiesterase-4 inhibitor roflumilast impacts Schistosoma mansoni ovipositing in vitro but displays only modest antischistosomal activity in vivo","volume":"208","author":"Botros","year":"2020","journal-title":"Exp. Parasitol."},{"key":"10.1016\/bs.apar.2022.05.002_bb0035","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.phymed.2017.11.001","article-title":"In vivo schistosomicidal activity of 7-epiclusianone and its quantification in the plasma of healthy and Schistosoma mansoni infected mice using UPLC-MS\/MS","volume":"38","author":"Castro","year":"2018","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/bs.apar.2022.05.002_bb0040","doi-asserted-by":"crossref","first-page":"85","DOI":"10.4269\/ajtmh.1987.37.85","article-title":"Variation of hepatic fibrosis and granuloma size among mouse strains infected with Schistosoma mansoni","volume":"37","author":"Cheever","year":"1987","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"9936","key":"10.1016\/bs.apar.2022.05.002_bb0045","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1016\/S0140-6736(13)61949-2","article-title":"Human schistosomiasis","volume":"383","author":"Colley","year":"2014","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/bs.apar.2022.05.002_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002617","article-title":"Phytol, a diterpene alcohol from chlorophyll, as a drug against neglected tropical disease schistosomiasis mansoni","volume":"8","author":"de Moraes","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/bs.apar.2022.05.002_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114045","article-title":"Circadian rhythm in pharmacokinetics and its relevance to chronotherapy","volume":"178","author":"Dong","year":"2020","journal-title":"Biochem. Pharmacol."},{"issue":"4","key":"10.1016\/bs.apar.2022.05.002_bb0060","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.pt.2019.01.004","article-title":"Genome-wide approaches to investigate anthelmintic resistance","volume":"35","author":"Doyle","year":"2019","journal-title":"Trends Parasitol."},{"issue":"4","key":"10.1016\/bs.apar.2022.05.002_bb0065","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1039\/D0MD00062K","article-title":"Chemotherapy for human schistosomiasis: how far have we come? What's new? Where do we go from here?","volume":"11","author":"Dziwornu","year":"2020","journal-title":"RSC Med. Chem."},{"issue":"2","key":"10.1016\/bs.apar.2022.05.002_bb0070","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/0014-4894(92)90176-B","article-title":"Schistosoma mansoni: mortality, pathophysiology, and susceptibility differences in male and female mice","volume":"75","author":"Eloi-Santos","year":"1992","journal-title":"Exp. Parasitol."},{"issue":"7","key":"10.1016\/bs.apar.2022.05.002_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009490","article-title":"The discovery of a novel series of compounds with single-dose efficacy against juvenile and adult Schistosoma species","volume":"15","author":"Gardner","year":"2021","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"2","key":"10.1016\/bs.apar.2022.05.002_bb0080","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF00389899","article-title":"Praziquantel, a new board-spectrum antischistosomal agent","volume":"52","author":"G\u00f6nnert","year":"1977","journal-title":"Z. Parasitenkd."},{"issue":"2","key":"10.1016\/bs.apar.2022.05.002_bb0085","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.actatropica.2012.09.014","article-title":"Population genetic structure of Schistosoma mansoni and Schistosoma haematobium from across six sub-Saharan African countries: implications for epidemiology, evolution and control","volume":"128","author":"Gower","year":"2013","journal-title":"Acta Trop."},{"issue":"6","key":"10.1016\/bs.apar.2022.05.002_bb0090","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1128\/AAC.06177-11","article-title":"Antischistosomal activities of mefloquine-related arylmethanols","volume":"56","author":"Ingram","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"issue":"9","key":"10.1016\/bs.apar.2022.05.002_bb0095","doi-asserted-by":"crossref","first-page":"4506","DOI":"10.1128\/AAC.01129-13","article-title":"Disposition of mefloquine and enpiroline is highly influenced by a chronic Schistosoma mansoni infection","volume":"57","author":"Ingram","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"issue":"7","key":"10.1016\/bs.apar.2022.05.002_bb0100","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1590\/0074-0276130207","article-title":"Imatinib activity on Schistosoma mansoni","volume":"108","author":"Katz","year":"2013","journal-title":"Mem. Inst. Oswaldo Cruz"},{"issue":"1","key":"10.1016\/bs.apar.2022.05.002_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000350","article-title":"Mefloquine\u2014an aminoalcohol with promising antischistosomal properties in mice","volume":"3","author":"Keiser","year":"2009","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"2","key":"10.1016\/bs.apar.2022.05.002_bb0110","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1128\/AAC.05371-11","article-title":"In vivo activity of aryl ozonides against Schistosoma species","volume":"56","author":"Keiser","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"10.1016\/bs.apar.2022.05.002_bb0115","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1093\/jac\/dkv016","article-title":"Aryl hydantoin Ro 13-3978, a broad-spectrum antischistosomal","volume":"70","author":"Keiser","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"issue":"2","key":"10.1016\/bs.apar.2022.05.002_bb0120","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.actatropica.2009.11.012","article-title":"Parasites and poverty: the case of schistosomiasis","volume":"113","author":"King","year":"2010","journal-title":"Acta Trop."},{"issue":"12","key":"10.1016\/bs.apar.2022.05.002_bb0125","doi-asserted-by":"crossref","first-page":"7364","DOI":"10.1128\/AAC.02394-15","article-title":"Pharmacokinetics of the antischistosomal lead ozonide OZ418 in uninfected mice determined by liquid chromatography-tandem mass spectrometry","volume":"60","author":"Leonidova","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/bs.apar.2022.05.002_bb0130","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ejpb.2004.03.001","article-title":"Classification of orally administered drugs on the World Health Organization model list of essential medicines according to the biopharmaceutics classification system","volume":"58","author":"Lindenberg","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/bs.apar.2022.05.002_bb0135","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41596-018-0101-y","article-title":"Life cycle maintenance and drug-sensitivity assays for early drug discovery in Schistosoma mansoni","volume":"14","author":"Lombardo","year":"2019","journal-title":"Nat. Protoc."},{"key":"10.1016\/bs.apar.2022.05.002_bb0140","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ejpb.2019.06.029","article-title":"Activity and pharmacokinetics of a praziquantel crystalline polymorph in the Schistosoma mansoni mouse model","volume":"142","author":"Lombardo","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1","key":"10.1016\/bs.apar.2022.05.002_bb0145","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1186\/s13071-019-3747-6","article-title":"Multi-center screening of the pathogen box collection for schistosomiasis drug discovery","volume":"12","author":"Maccesi","year":"2019","journal-title":"Parasit. Vectors"},{"issue":"3","key":"10.1016\/bs.apar.2022.05.002_bb0150","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1021\/acsinfecdis.8b00313","article-title":"Structure\u2013activity relationship and in vitro absorption, distribution, metabolism, excretion, and toxicity (ADMET) studies of N-aryl 3-trifluoromethyl pyrido[1,2-a]benzimidazoles that are efficacious in a mouse model of schistosomiasis","volume":"5","author":"Mayoka","year":"2019","journal-title":"ACS Infect, Dis."},{"issue":"9","key":"10.1016\/bs.apar.2022.05.002_bb0155","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.1128\/AAC.02741-14","article-title":"Activity of praziquantel enantiomers and main metabolites against Schistosoma mansoni","volume":"58","author":"Meister","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/bs.apar.2022.05.002_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000357","article-title":"Taste, a new incentive to switch to (R)-praziquantel in schistosomiasis treatment","volume":"3","author":"Meyer","year":"2009","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"3","key":"10.1016\/bs.apar.2022.05.002_bb0165","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1006\/expr.1997.4148","article-title":"Schistosoma mansoni: susceptibility differences between male and female mice can be mediated by testosterone during early infection","volume":"85","author":"Nakazawa","year":"1997","journal-title":"Exp. Parasitol."},{"issue":"4","key":"10.1016\/bs.apar.2022.05.002_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007951","article-title":"Schistosome migration in the definitive host","volume":"14","author":"Nation","year":"2020","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"13","key":"10.1016\/bs.apar.2022.05.002_bb0175","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.1021\/jm200227r","article-title":"Antimalarial Pyrido[1,2-a]benzimidazoles","volume":"54","author":"Ndakala","year":"2011","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/bs.apar.2022.05.002_bb0180","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1021\/acsinfecdis.6b00205","article-title":"Antischistosomal activity of pyrido[1,2-a]benzimidazole derivatives and correlation with inhibition of beta-hematin formation","volume":"3","author":"Okombo","year":"2017","journal-title":"ACS Infect, Dis."},{"issue":"4","key":"10.1016\/bs.apar.2022.05.002_bb0185","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1093\/jac\/dkt491","article-title":"The little we know about the pharmacokinetics and pharmacodynamics of praziquantel (racemate and R-enantiomer)","volume":"69","author":"Olliaro","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/bs.apar.2022.05.002_bb0190","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.coph.2018.06.004","article-title":"Acting beyond 2020: better characterization of praziquantel and promising antischistosomal leads","volume":"42","author":"Panic","year":"2018","journal-title":"Curr. Opin. Pharmacol."},{"issue":"7","key":"10.1016\/bs.apar.2022.05.002_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003962","article-title":"Activity profile of an FDA-approved compound library against Schistosoma mansoni","volume":"9","author":"Panic","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"12","key":"10.1016\/bs.apar.2022.05.002_bb0200","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01142-17","article-title":"Immunohistochemical investigations of treatment with Ro 13-3978, praziquantel, oxamniquine, and mefloquine in Schistosoma mansoni-infected mice","volume":"61","author":"Panic","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/bs.apar.2022.05.002_bb0205","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.pt.2019.11.002","article-title":"The journey to discovering a flatworm target of praziquantel: a Long TRP","volume":"36","author":"Park","year":"2020","journal-title":"Trends Parasitol."},{"issue":"1","key":"10.1016\/bs.apar.2022.05.002_bb0210","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1021\/acsinfecdis.8b00220","article-title":"Early antischistosomal leads identified from in vitro and in vivo screening of the Medicines for Malaria Venture Pathogen Box","volume":"5","author":"Pasche","year":"2018","journal-title":"ACS Infect Dis."},{"issue":"5","key":"10.1016\/bs.apar.2022.05.002_bb0215","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1021\/acsinfecdis.0c00278","article-title":"Expanding the activity profile of pyrido[1,2-a]benzimidazoles: synthesis and evaluation of novel N1-1-Phenylethanamine derivatives against Schistosoma mansoni","volume":"7","author":"Probst","year":"2020","journal-title":"ACS Infect. Dis."},{"issue":"10","key":"10.1016\/bs.apar.2022.05.002_bb0220","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1093\/jac\/dkaa247","article-title":"Efficacy, metabolism and pharmacokinetics of Ro 15-5458, a forgotten schistosomicidal 9-acridanone hydrazone","volume":"75","author":"Probst","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"issue":"10","key":"10.1016\/bs.apar.2022.05.002_bb0225","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00615-21","article-title":"In vitro, in vivo, and ADME evaluation of SF(5)-containing N,N\u2019-diarylureas as antischistosomal agents","volume":"65","author":"Probst","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/bs.apar.2022.05.002_bb0230","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s12915-021-01189-9","article-title":"Daily rhythms in gene expression of the human parasite Schistosoma mansoni","volume":"19","author":"Rawlinson","year":"2021","journal-title":"BMC Biol."},{"issue":"3","key":"10.1016\/bs.apar.2022.05.002_bb0235","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.ijantimicag.2017.06.005","article-title":"Antiparasitic activity of nerolidol in a mouse model of schistosomiasis","volume":"50","author":"Silva","year":"2017","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/bs.apar.2022.05.002_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.113387","article-title":"Brazilian red propolis exhibits antiparasitic properties in vitro and reduces worm burden and egg production in an mouse model harboring either early or chronic Schistosoma mansoni infection","volume":"264","author":"Silva","year":"2021","journal-title":"J. Ethnopharmacol."},{"issue":"5","key":"10.1016\/bs.apar.2022.05.002_bb0245","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1021\/acsinfecdis.0c00542","article-title":"Alternatives to praziquantel for the prevention and control of schistosomiasis","volume":"7","author":"Spangenberg","year":"2021","journal-title":"ACS Infect. Dis."},{"issue":"2","key":"10.1016\/bs.apar.2022.05.002_bb0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010288","article-title":"Chromosome-level genome of Schistosoma haematobium underpins genome-wide explorations of molecular variation","volume":"18","author":"Stroehlein","year":"2022","journal-title":"PLoS Pathog."},{"issue":"6","key":"10.1016\/bs.apar.2022.05.002_bb0255","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.4269\/ajtmh.14-0029","article-title":"Antischistosomal versus antiandrogenic properties of aryl hydantoin Ro 13-3978","volume":"90","author":"Wang","year":"2014","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"23","key":"10.1016\/bs.apar.2022.05.002_bb0260","doi-asserted-by":"crossref","first-page":"10705","DOI":"10.1021\/acs.jmedchem.6b01410","article-title":"Revisiting the SAR of the antischistosomal aryl hydantoin (Ro 13-3978)","volume":"59","author":"Wang","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/bs.apar.2022.05.002_bb0265","series-title":"Ending the neglect to attain the sustainable development goals: A road map for neglected tropical diseases 2021\u20132030","author":"WHO","year":"2020"},{"issue":"3","key":"10.1016\/bs.apar.2022.05.002_bb0270","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.ijpddr.2018.10.004","article-title":"TPT sulfonate, a single, oral dose schistosomicidal prodrug: In vivo efficacy, disposition and metabolic profiling","volume":"8","author":"Wolfe","year":"2018","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"issue":"3","key":"10.1016\/bs.apar.2022.05.002_bb0275","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.bmcl.2017.12.064","article-title":"Progress in antischistosomal N,N'-diaryl urea SAR","volume":"28","author":"Wu","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"1","key":"10.1016\/bs.apar.2022.05.002_bb0280","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s13071-020-04140-z","article-title":"H1-antihistamines as antischistosomal drugs: in vitro and in vivo studies","volume":"13","author":"Xavier","year":"2020","journal-title":"Parasit. Vectors"},{"issue":"4","key":"10.1016\/bs.apar.2022.05.002_bb0285","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1128\/AAC.01537-06","article-title":"In vitro and in vivo activities of synthetic trioxolanes against major human schistosome species","volume":"51","author":"Xiao","year":"2007","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Advances in Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065308X22000185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065308X22000185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T07:58:44Z","timestamp":1753430324000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0065308X22000185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"ISBN":["9780323989497"],"references-count":56,"URL":"https:\/\/doi.org\/10.1016\/bs.apar.2022.05.002","relation":{},"ISSN":["0065-308X"],"issn-type":[{"value":"0065-308X","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]}}}